Cancer Res. 2006 Jan 1;66(1):95-106.

Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.

Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, Boivin GP, Furth EE, Furukawa T, Klein A, Klimstra DS, Kloppel G, Lauwers GY, Longnecker DS, Luttges J, Maitra A, Offerhaus GJ, Pérez-Gallego L, Redston M, Tuveson DA.

Source

Department of Pathology, The Sol Goldman Center for Pancreatic Cancer Research, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA. rhruban@jhmi.edu

Abstract

Several diverse genetically engineered mouse models of pancreatic exocrine neoplasia have been developed. These mouse models have a spectrum of pathologic changes; however, until now, there has been no uniform nomenclature to characterize these changes. An international workshop, sponsored by The National Cancer Institute and the University of Pennsylvania, was held from December 1 to 3, 2004 with the goal of establishing an internationally accepted uniform nomenclature for the pathology of genetically engineered mouse models of pancreatic exocrine neoplasia. The pancreatic pathology in 12 existing mouse models of pancreatic neoplasia was reviewed at this workshop, and a standardized nomenclature with definitions and associated images was developed. It is our intention that this nomenclature will standardize the reporting of genetically engineered mouse models of pancreatic exocrine neoplasia, that it will facilitate comparisons between genetically engineered mouse models and human pancreatic disease, and that it will be broad enough to accommodate newly emerging mouse models of pancreatic neoplasia.

PMID:: 16397221; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms, Grant Support

Publication Types

MeSH Terms

Grant Support

LinkOut - more resources

Full Text Sources

HighWire Press

Other Literature Sources

Medical

Pancreatic Cancer - MedlinePlus Health Information

Miscellaneous

Mouse Genome Informatics (MGI)

Supplemental Content

Related citations

Review Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. [Cancer Res. 2004]
Review Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.
Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, et al. Cancer Res. 2004 Mar 15; 64(6):2270-305.
Pancreatic cancer in mice and man: the Penn Workshop 2004. [Cancer Res. 2006]
Pancreatic cancer in mice and man: the Penn Workshop 2004.
Hruban RH, Rustgi AK, Brentnall TA, Tempero MA, Wright CV, Tuveson DA. Cancer Res. 2006 Jan 1; 66(1):14-7.
Review The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. [Oncogene. 2000]
Review The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.
Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Wakefield LM, et al. Oncogene. 2000 Feb 21; 19(8):968-88.
Review Validity of mouse mammary tumour models for human breast cancer: comparative pathology. [Microsc Res Tech. 2001]
Review Validity of mouse mammary tumour models for human breast cancer: comparative pathology.
Cardiff RD. Microsc Res Tech. 2001 Jan 15; 52(2):224-30.
Review Modeling pancreatic cancer in animals to address specific hypotheses. [Methods Mol Med. 2005]
Review Modeling pancreatic cancer in animals to address specific hypotheses.
Grippo PJ, Sandgren EP. Methods Mol Med. 2005; 103:217-43.

See reviews... See all...

Cited by 54 PubMed Central articles

Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. [J Clin Invest. 2012]
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.
Collins MA, Bednar F, Zhang Y, Brisset JC, Galbán S, Galbán CJ, Rakshit S, Flannagan KS, Adsay NV, Pasca di Magliano M. J Clin Invest. 2012 Feb 1; 122(2):639-53. Epub 2012 Jan 9.
Retinoid signaling in pancreatic cancer, injury and regeneration. [PLoS One. 2011]
Retinoid signaling in pancreatic cancer, injury and regeneration.
Colvin EK, Susanto JM, Kench JG, Ong VN, Mawson A, Pinese M, Chang DK, Rooman I, O'Toole SA, Segara D, et al. PLoS One. 2011; 6(12):e29075. Epub 2011 Dec 29.
FLIM-FRET imaging in vivo reveals 3D-environment spatially regulates RhoGTPase activity during cancer cell invasion. [Small Gtpases. 2011]
FLIM-FRET imaging in vivo reveals 3D-environment spatially regulates RhoGTPase activity during cancer cell invasion.
McGhee EJ, Morton JP, Von Kriegsheim A, Schwarz JP, Karim SA, Carragher NO, Sansom OJ, Anderson KI, Timpson P. Small Gtpases. 2011 Jul; 2(4):239-244. Epub 2011 Jul 1.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Pathology of genetically engineered mouse models of pancreatic exocrine cancer: ...
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
Cancer Res. 2006 Jan 1 ;66(1):95-106.

PubMed
Lightning injuries: prevention and on-site treatment in mountains and remote are...
Lightning injuries: prevention and on-site treatment in mountains and remote areas. Official guidelines of the International Commission for Mountain Emergency Medicine and the Medical Commission of the International Mountaineering and Climbing Federation (ICAR and UIAA MEDCOM).
Resuscitation. 2005 Jun ;65(3):369-72.

PubMed
Metaplastic breast carcinoma with melanocytic differentiation.
Metaplastic breast carcinoma with melanocytic differentiation.
Pathol Int. 2009 Sep ;59(9):676-80.

PubMed
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori e...
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial.
Ann Intern Med. 2007 Apr 17 ;146(8):556-63.

PubMed
Itraconazole versus terbinafine in the management of onychomycosis: an overview.
Itraconazole versus terbinafine in the management of onychomycosis: an overview.
J Dermatolog Treat. 2003 Jan ;14(1):30-42.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: